Association of CD49d and CD44 in chronic lymphocytic leukemia patients and their effects on response to fludarabine, cyclophosphamide, and rituximab therapy - Egyptian Knowledge Bank - troweb

369893

Association of CD49d and CD44 in chronic lymphocytic leukemia patients and their effects on response to fludarabine, cyclophosphamide, and rituximab therapy

Article

Last updated: 29 Dec 2024

Overview Similar Items

Article

CD49 Expression in Chronic Lymphocytic Leukemia B-Cell and Non-Hodgkin Lymphoma

Article

Prognostic roles of both CD49d and trisomy12 in chronic lymphocytic leukemia (CLL)

Article

Study of CD184 (CXCR4) Expression in Chronic Lymphocytic Leukemia Patients

Article

Study of CD160 expression in B-chronic Lymphocytic Leukemia

Article

Prognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia

Article

B-cell-receptor-targeted therapy in CLL

Article

The Role of Expression of Lymphoid Enhancer-Binding Factor-1 (LEF-1) in Patients with Chronic Lymphocytic Leukemia

Article

Significance of tumor necrosis factor- α and B2 microglobulin in patients having chronic lymphocytic leukemia

Article

Significance of Interleukin-22 and CD38 in Chronic Lymphocytic Leukemia

Article

The Regulatory Role of CD26 And Its Expression in Chronic Lymphocytic Leukemia and B-Cell Non-Hodgkin Lymphoma